Selpercatinib
Brand name: Retevmo
E*
DILI Likelihood
Score E* — Unproven but Suspected
This drug is suspected to be capable of causing liver injury, but there are no convincing cases in the medical literature.
Cases may have been reported to regulatory agencies, but specifics supportive of causality are not available. The agent is unproven, but suspected to cause liver injury.
Classification
Search another medication
No article link available. Search directly at livertox.nih.gov.